albinterferon alfa-2b

Novartis Halts Development of Two Drugs: Biotech's Latest Tribulations
Seeking Alpha
Mon, 10/11/10 - 11:20 am
Novartis
Actelion
AstraZeneca
Human Genome
JNJ
ONYX Pharmaceuticals
Pfizer
Rosetta Genomics
Targacept
Mycograb
albinterferon alfa-2b